Global Technology Manufacturer Selects Kneat to Drive Digital Transformation Across Enterprise and Manufacturing Sites
Kneat (OTCQC: KSIOF) has secured a significant Master Services Agreement with a major U.S.-based multinational manufacturer of advanced devices and components. The client company, which employs over 30,000 people across 30+ countries, will implement the Kneat Gx platform for two primary purposes:
The platform will be used for Computer Systems Validation across enterprise applications and for Commissioning, Qualification and Validation at 18 manufacturing sites within its medical and healthcare division. This strategic partnership demonstrates Kneat's expanding presence in the life sciences sector beyond pharmaceuticals.
Kneat (OTCQC: KSIOF) ha assicurato un significativo Master Services Agreement con un importante produttore multinazionale statunitense di dispositivi e componenti avanzati. L'azienda cliente, che impiega oltre 30.000 persone in 30+ paesi, implementerà la Kneat Gx platform per due scopi principali:
La piattaforma sarà utilizzata per la Computer Systems Validation in applicazioni aziendali e per Commissioning, Qualification and Validation in 18 siti di produzione all'interno della sua divisione medica e sanitaria. Questa partnership strategica dimostra l'espansione di Kneat nel settore delle scienze della vita oltre i medicinali.
Kneat (OTCQC: KSIOF) ha asegurado un importante Master Services Agreement con un importante fabricante multinacional con sede en Estados Unidos, especializado en dispositivos y componentes avanzados. La empresa cliente, que emplea a más de 30,000 personas en 30+ países, implementará la Kneat Gx platform para dos funciones principales:
La plataforma se utilizará para la Validación de Sistemas Informáticos en aplicaciones empresariales y para Commissioning, Qualification and Validation en 18 sitios de fabricación dentro de su división médica y de atención sanitaria. Esta asociación estratégica demuestra la creciente presencia de Kneat en el sector de las ciencias de la vida, más allá de los productos farmacéuticos.
Kneat (OTCQC: KSIOF)은 고급 기기 및 부품을 제조하는 미국에 본사를 둔 주요 다국적 기업과 중요한 마스터 서비스 계약(Master Services Agreement)을 체결했습니다. 고객사는 30개국 이상에서 30,000명 이상을 고용하고 있으며, Kneat Gx platform를 두 가지 주요 목적에 사용합니다:
플랫폼은 기업 전반의 응용 시스템에 대한 컴퓨터 시스템 검증 및 의료 및 건강 관리 부문의 18개 제조 시설에서의 시운전, 자격 및 검증에 사용될 것입니다. 이 전략적 파트너십은 Kneat의 제약 분야를 넘어 생명과학 부문에서의 확장을 보여줍니다.
Kneat (OTCQC: KSIOF) a obtenu un contrat-cadres important Master Services Agreement avec un grand fabricant multinational américain d'appareils et de composants avancés. L'entreprise cliente, qui emploie plus de 30 000 personnes dans plus de 30 pays, va implémenter la Kneat Gx platform pour deux objectifs principaux :
La plateforme sera utilisée pour la Validation des systèmes informatiques dans les applications d'entreprise et pour la Mise en service, Qualification et Validation dans 18 sites de fabrication au sein de sa division médicale et sanitaire. Ce partenariat stratégique démontre l'expansion de Kneat dans le secteur des sciences de la vie au-delà des produits pharmaceutiques.
Kneat (OTCQC: KSIOF) hat einen bedeutenden Master Services Agreement mit einem großen multinationalen Hersteller von fortschrittlichen Geräten und Komponenten mit Sitz in den USA gesichert. Das Kundennunternehmen, das über 30.000 Mitarbeiter in mehr als 30 Ländern beschäftigt ist, wird die Kneat Gx platform für zwei Hauptzwecke einsetzen:
Die Plattform wird für die Validierung von Computersystemen über Unternehmensanwendungen und für Inbetriebnahme, Qualifizierung und Validierung an 18 Fertigungsstandorten innerhalb seiner Medizin- und Gesundheitsabteilung genutzt. Diese strategische Partnerschaft zeigt Kneats wachsende Präsenz im Bereich der Life Sciences über die Pharmazeutika hinaus.
Kneat (OTCQC: KSIOF) أبرمت اتفاقية خدمات رئيسية Master Services Agreement مع مصنع متعدد الجنسيات أمريكي كبير ينتج أجهزة ومكونات متقدمة. الشركة العميلة، التي توظف أكثر من 30,000 موظف عبر 30 دولة، ستطبق منصة Kneat Gx لغرضين رئيسيين:
ستستخدم المنصة لـ الاعتماد على أنظمة الحاسوب عبر تطبيقات المؤسسة ولـ التشغيل، والتأهيل والتحقق في 18 موقعاً للتصنيع ضمن قسمها الطبي والرعاية الصحية. هذه الشراكة الاستراتيجية تُظهر توسيع حضور Kneat في قطاع علوم الحياة بما يتجاوز الأدوية.
Kneat (OTCQC: KSIOF) 已与一家总部位于美国的全球大型制造商就先进设备和组件签署了重要的主服务协议（Master Services Agreement）。该客户公司在全球30多个国家拥有超过30,000名员工，将为两个主要目的实施Kneat Gx 平台：
该平台将用于企业应用的计算机系统验证以及在其医疗与健康护理部门的18个制造地点进行的调试、确认与验证。这一战略伙伴关系显示出 Kneat 在生命科学领域的扩展，超越药物领域。
- Expansion into broader life sciences sector beyond pharmaceuticals
- Implementation across 18 manufacturing sites indicates large-scale deployment
- Strategic partnership with a major multinational company (30,000+ employees)
- Demonstrates platform versatility across multiple validation processes
- None.
LIMERICK, Ireland, Sept. 25, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading multinational manufacturer of advanced devices and components including industrial, consumer, and MedTech, (“the Company”) has signed a Master Services Agreement with Kneat.
Headquartered in the United States, the Company employs more than 30,000 people and has a presence in over 30 countries worldwide. As part of this agreement, the Company will implement the Kneat Gx platform initially for two critical use cases: Computer Systems Validation across its own enterprise applications; and Commissioning, Qualification and Validation at 18 manufacturing sites within its dedicated medical and healthcare affiliate.
"This strategic win highlights Kneat’s unique ability to digitize the full spectrum of validation processes, from manufacturing equipment through to enterprise-wide IT systems,” said Eddie Ryan, CEO of Kneat. “It underscores the power of our platform to deliver compliance, efficiency and scalability not only within the pharmaceutical industry but across the broader life sciences sector. We look forward to working with this innovation leader to deliver on their efficiency and compliance goals.”
This agreement further expands Kneat’s validation footprint within highly regulated processes and reinforces its position as the platform of choice for global leaders seeking to streamline quality, compliance and operational performance at scale.
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Independent customer studies have shown Kneat Gx to reduce labor hours associated with validation documentation by more than
For further information:
Katie Keita, Kneat Investor Relations
P: + 1 902-450-2660
E: investors@kneat.com
FAQ
What is the scope of Kneat's new contract with the multinational manufacturer?
How many manufacturing sites will implement Kneat's Gx platform under this agreement?
What is the global presence of the company that signed with Kneat (KSIOF)?
What are the main use cases for Kneat's platform in this agreement?
